Phaseline

Targets › EBOV

EBOV: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 4; Infectious disease; next expected readout Jun 2027.

Open in Phaseline: the race on EBOV, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
EpicentreERVEBO
Live attenuated Zaire ebolavirus vaccine
EBOVPhase 4EbolaJun 2027

Conditions

Ebola (1)

Modalities

other (1)

Companies

Epicentre (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.